TY - JOUR
T1 - Classification of multiple sclerosis based on patterns of CNS regional atrophy covariance
AU - Tsagkas, Charidimos
AU - Parmar, Katrin
AU - Pezold, Simon
AU - Barro, Christian
AU - Chakravarty, Mallar M.
AU - Gaetano, Laura
AU - Naegelin, Yvonne
AU - Amann, Michael
AU - Papadopoulou, Athina
AU - Wuerfel, Jens
AU - Kappos, Ludwig
AU - Kuhle, Jens
AU - Sprenger, Till
AU - Granziera, Cristina
AU - Magon, Stefano
N1 - Publisher Copyright:
© 2021 The Authors. Human Brain Mapping published by Wiley Periodicals LLC.
PY - 2021/6/1
Y1 - 2021/6/1
N2 - There is evidence that multiple sclerosis (MS) pathology leads to distinct patterns of volume loss over time (VLOT) in different central nervous system (CNS) structures. We aimed to use such patterns to identify patient subgroups. MS patients of all classical disease phenotypes underwent annual clinical, blood, and MRI examinations over 6 years. Spinal, striatal, pallidal, thalamic, cortical, white matter, and T2-weighted lesion volumes as well as serum neurofilament light chain (sNfL) were quantified. CNS VLOT patterns were identified using principal component analysis and patients were classified using hierarchical cluster analysis. 225 MS patients were classified into four distinct Groups A, B, C, and D including 14, 59, 141, and 11 patients, respectively). These groups did not differ in baseline demographics, disease duration, disease phenotype distribution, and lesion-load expansion. Interestingly, Group A showed pronounced spinothalamic VLOT, Group B marked pallidal VLOT, Group C small between-structure VLOT differences, and Group D myelocortical volume increase and pronounced white matter VLOT. Neurologic deficits were more severe and progressed faster in Group A that also had higher mean sNfL levels than all other groups. Group B experienced more frequent relapses than Group C. In conclusion, there are distinct patterns of VLOT across the CNS in MS patients, which do not overlap with clinical MS subtypes and are independent of disease duration and lesion-load but are partially associated to sNfL levels, relapse rates, and clinical worsening. Our findings support the need for a more biologic classification of MS subtypes including volumetric and body-fluid markers.
AB - There is evidence that multiple sclerosis (MS) pathology leads to distinct patterns of volume loss over time (VLOT) in different central nervous system (CNS) structures. We aimed to use such patterns to identify patient subgroups. MS patients of all classical disease phenotypes underwent annual clinical, blood, and MRI examinations over 6 years. Spinal, striatal, pallidal, thalamic, cortical, white matter, and T2-weighted lesion volumes as well as serum neurofilament light chain (sNfL) were quantified. CNS VLOT patterns were identified using principal component analysis and patients were classified using hierarchical cluster analysis. 225 MS patients were classified into four distinct Groups A, B, C, and D including 14, 59, 141, and 11 patients, respectively). These groups did not differ in baseline demographics, disease duration, disease phenotype distribution, and lesion-load expansion. Interestingly, Group A showed pronounced spinothalamic VLOT, Group B marked pallidal VLOT, Group C small between-structure VLOT differences, and Group D myelocortical volume increase and pronounced white matter VLOT. Neurologic deficits were more severe and progressed faster in Group A that also had higher mean sNfL levels than all other groups. Group B experienced more frequent relapses than Group C. In conclusion, there are distinct patterns of VLOT across the CNS in MS patients, which do not overlap with clinical MS subtypes and are independent of disease duration and lesion-load but are partially associated to sNfL levels, relapse rates, and clinical worsening. Our findings support the need for a more biologic classification of MS subtypes including volumetric and body-fluid markers.
KW - MRI
KW - atrophy
KW - biomarkers
KW - classification
KW - demyelinating autoimmune diseases
KW - multiple sclerosis
KW - neurodegeneration
UR - http://www.scopus.com/inward/record.url?scp=85101517324&partnerID=8YFLogxK
U2 - 10.1002/hbm.25375
DO - 10.1002/hbm.25375
M3 - Article
C2 - 33624390
AN - SCOPUS:85101517324
SN - 1065-9471
VL - 42
SP - 2399
EP - 2415
JO - Human Brain Mapping
JF - Human Brain Mapping
IS - 8
ER -